Browse Articles
Discover research articles across all indexed journals
Tislelizumab in combination with carboplatin and albumin–binding paclitaxel for neoadjuvant therapy in head and neck squamous cell carcinoma: A prospective, phase II clinical study.
226 Background: Surgery followed by adjuvant therapy remains the standard treatment for locally advanced head and neck squamous cell carcinoma (LA–HNSCC). Neoadjuvant chemotherapy alone has not improved survival. Although perioperative immunotherapy has been approved based on the KEYNOTE–689 trial, pathological response and event–free survival (EFS) remain modest. Immunotherapy combined with chemotherapy may enhance antitumor efficacy, but prospective evidence remains limited. Methods: This single–center, prospective, single–arm phase II trial (NCT05941338) enrolled 100 treatment–naïve patients with resectable stage III–IVA (AJCC 8th edition) HNSCC. Patients received two cycles of neoadjuvant tislelizumab (200 mg Q3W), carboplatin (AUC 5), and albumin–bound paclitaxel (260 mg/m²), followed by surgery and risk–adapted adjuvant therapy. Primary endpoints were major pathological response (MPR; ≤10% residual viable tumor) and serious adverse events. Secondary endpoints included EFS, overall survival (OS), pathological complete response (pCR), radiological response, and surgical feasibility. Results: Ninety–five patients (95.0%) underwent definitive surgery. The objective radiological response rate was 83.0%. Pathological assessment showed an MPR rate of 57.9%, including pCR in some patients. No treatment–related surgical delays or deaths occurred. Grade 3–4 treatment–related adverse events occurred in 8%. At a median follow–up of 23.8 months, 12–month EFS and OS rates were 90.5% and 98.9%, respectively. Patients achieving MPR had significantly superior EFS compared with non–MPR patients (12–month EFS: 98.1% vs. 80.0%; P = 0.001; HR 0.072). Postoperative adjuvant modality was not associated with EFS. In contrast, baseline lymph node positivity, ypN2–3 disease, extranodal extension, and advanced pathological T stage were significantly associated with inferior EFS. Conclusions: Neoadjuvant tislelizumab combined with carboplatin and albumin–bound paclitaxel demonstrated favorable safety, a high MPR rate, and encouraging short–term EFS in resectable LA–HNSCC. MPR was strongly associated with postoperative EFS, supporting its potential role as an early surrogate endpoint. Pathological risk stratification may guide individualized adjuvant therapy, enabling treatment de–escalation in low–risk patients and intensification in high–risk populations. Clinical trial information: NCT05941338 .
Evaluating a hybrid AI-powered digital health guide to improve informed decision making and streamline access to genetic testing for hereditary cancer.
319 Background: Despite expanded testing guidelines, lower costs, and clear clinical utility, uptake of genetic testing remains low. Traditional referral-based models that rely on separate clinician visits, including telehealth, do not meet the needs of many patients. Chatbots represent a promising approach to support informed decision making, supplement or replace genetic counseling, improve access to genetic care delivery, and enhance health outcomes across diverse populations. The study’s goal was to develop and evaluate the feasibility, acceptability, and preliminary efficacy of a hybrid AI-powered digital health guide (DHG) designed to promote informed decision making and improve guideline-based genetic testing for hereditary cancer predisposition. Methods: The DHG prototype was developed following community-engaged formative research (focus groups (n = 51), and semi-structured interviews (n = 14)) with cancer patients and at-risk relatives and guided by Ottawa Decision Support Framework. Cancer patients meeting germline testing criteria were ascertained from the electronic health record and recruited through proactive outreach. The DHG was refined through user (content-focused) and usability (functionality-focused) testing. In the pilot trial (n = 28), probands were randomized to the DHG or enhanced usual care (EUC) arms. Qualitative data were analyzed using the Framework Method and quantitative data were summarized with descriptive statistics and t-tests. Methods for minimizing hallucinations from the large language model DHG chat function were used. Results: In response to patient and relative input, we incorporated features to enhance trust, accessibility, and cultural relevance, including an interculturally competent, multimedia DHG with text and voice options; clear and actionable genetic information; patient testimonials; cascade testing; and flexible options for result delivery. Users’ feedback also led to clearer language, improved navigation, and stronger messaging regarding privacy and data security. The Chatbot Usability Questionnaire score for the DHG was 70.3 (IQR = 12.5), indicating good acceptability. The trial showed genetic testing uptake was substantially higher in the DHG arm (73.3%) compared with enhanced usual care (EUC; 7.7%). Pretest genetic counseling was requested by 1 of 13 EUC participants and none of 15 DHG participants. DHG participants reported significantly lower decisional conflict (33.37 ± 21.09) and decision regret (17.5±16.50) compared with EUC (53.25±22.66 and 37.08±17.38, respectively; p < 0.05). Conclusions: Our approach has strong potential to increase access, remove barriers, streamline care, guide decision making, and inform prevention and surveillance practices for high-risk patients. Clinical trial information: NCT06184867 .
Selectivity Reversal from CO to Ethylene Products in CO <sub>2</sub> Photoreduction via Electronic Modulation of SnS <sub>2</sub> Using a Vinyl-Bridged Porous Organic Polymer
Beyond Hyperfluorescence: Leveraging a Host‐Guest Exciplex to Significantly Suppress the Efficiency Roll‐Off and Improve the Operational Stability in Narrowband Emissive Devices
ABSTRACT Narrowband emissive devices using multiple resonance (MR) thermally activated delayed fluorescence (TADF) emitters show strong efficiency roll‐offs and low operational stability, largely due to the low reverse intersystem crossing (RISC) rates ( k RISC ) of the emitters. TADF/phosphorescence‐sensitized fluorescence (i.e., hyperfluorescence) effectively solves this issue but requires a suitable sensitizer. Here, a “host‐guest exciplex promoted RISC” strategy effectively solves the issue beyond the hyperfluorescence mechanism. Three electron‐transporting hosts with a 2,4,6‐triphenyl‐1,3,5‐triazine motif, namely SF3‐TRZ , SF3‐TRZ‐DBF , and SF3‐TRZ‐DBSe , are developed for a typical MR‐TADF guest (DtBuCzB). The exciplex formed between the host and DtBuCzB effectively promotes the RISC of DtBuCzB, especially for selenium‐embedded SF3‐TRZ‐DBSe . The host‐guest films show narrowband emission from DtBuCzB, with the k RISC of the [ SF3‐TRZ‐DBSe : DtBuCzB] film being boosted by nearly 60‐fold to 4.7 × 10 5 s −1 . A narrowband blue‐green organic light‐emitting diode (OLED) based on a [ SF3‐TRZ‐DBSe : DtBuCzB] emissive layer shows maximum external quantum efficiency (EQE max )/EQE at 1000 cd m −2 (EQE 1000 ) of 30.1%/28.1%, with the EQE 1000 being the highest and the efficiency roll‐off being the lowest among narrowband OLEDs (including hyperfluorescence ones) based on DtBuCzB reported so far. The device also shows markedly improved operational stability compared to counterpart devices using the other two hosts or counterpart hyperfluorescence devices.
Performance characterization of non-Lambertian beams for 6G visible-light inter-satellite links
Abstract Visible-light inter-satellite communication is a promising physical-layer option for secure and interference-resilient 6G satellite networking. However, most analytical studies still assume Lambertian emission, which limits insight into emitters with asymmetric or multi-lobe radiation patterns. This paper presents a controlled analytical framework for Lambertian, Z-Power, and non-symmetric power-weighted (NSPW) beams using consistent transmitter–receiver modeling, channel-gain, receiver-noise, signal-to-noise ratio (SNR), and bit error rate (BER) formulations, including solar-background effects under Fraunhofer-line operation. The analysis considers six design dimensions: link distance, irradiance angle, transmitted optical power, receiver-bandwidth scaling, optical-filter background leakage, and beam azimuth rotation. The results show a clear operating-regime transition: Lambertian emission is competitive for near-aligned links, whereas non-Lambertian beams offer markedly higher robustness at wide irradiance angles. In a representative proximity-case stress point (0.5 km, $$80^\circ$$ irradiance angle), Z-Power and NSPW links achieve about 4.7 dB and $$-9.7$$ dB, respectively, while the Lambertian baseline remains near $$-55.4$$ dB, corresponding to gains of approximately 60 dB and 45.7 dB. The bandwidth, distance-scaling, and link-budget discussions clarify that these values are beam-profile sensitivity margins rather than a flight-qualified payload budget. Overall, the findings provide a practical roadmap for beam selection, link-margin interpretation, and attitude-aware adaptation in robust 6G visible-light inter-satellite communication systems.
Unravelling the Formation and Evolution Mechanism of Solid Electrolyte Interphase Toward Stable and Rapid Sodium Storage
ABSTRACT The development of sodium‐ion battery (SIB) anode materials is limited by the instability of the solid electrolyte interphase (SEI) and unclear degradation mechanisms, which severely restrict their rate performance and cycle life. To address these challenges, we synthesize Co 1.29 Ni 1.71 O 4 /NiFe 2 O 4 heterostructures as SIB anodes through high‐temperature calcination of a tri‐metallic layered double hydroxide. Density functional theory and molecular dynamics (MD) simulations reveal that this design can rationally modulate the electronic structure of anodes, as well as the absorption and diffusion properties of ions, which promote an efficient desolvation process and induce the directional formation of a rich inorganic SEI layer, thereby enabling rapid and stable sodium storage. Notably, by investigating the variation in SEI components during cycling, we have, for the first time, established a direct correlation between the evolution of the key component NaF in the SEI layer and the characteristic four‑stage (increase‑drop‑recovery‑decay) capacity fluctuations in SIBs. Consequently, a new perspective on battery degradation mechanisms involving temporal and spatial heterogeneity at the electrode/electrolyte interface is proposed. These groundbreaking insights offer crucial theoretical foundations and new perspectives for a deeper understanding of interface formation and evolution mechanisms. They also provide valuable guidance for designing high‐performance SIBs through electrode interface engineering strategies.
Bio‐Ionic Liquid‐Induced Rapid Self‐Initiating Tough Ionogels for In Situ Adhesion
ABSTRACT Synthesis of ionogels by photoinitiation and thermal initiation suffers from strict conditions and poor biocompatibility. In addition, achieving high mechanical strength and strong adhesive strength simultaneously remains difficult for ionogels. Herein, we report a bio‐ionic liquid‐induced self‐initiated strategy for the rapid and in situ polymerization mediated by liquid metal, which enables the fabrication of tough ionogels with favorable biocompatibility and robust interfacial adhesion. The malic acid/L‐(−)‐carnitine‐based ionic liquid disrupted the surface oxide layer of the liquid metal to accelerate in situ polymerization while simultaneously constructing a dynamic topological network through strong, reversible interactions with the polymer. This endowed the ionogel with high fracture strength (7.2 MPa), toughness (41.7 MJ m −3 ), and strong adhesion (7.6 MPa on glass). Ionogels exhibited photothermal responsiveness, enabling thermally reversible adhesion and real‐time adhesion states monitoring. Owing to good tissue adhesion, ionogels served as bioelectrodes for stable acquisition of physiological signals. This work offers meaningful guidance for the rational design of ionogels for applications in intelligent adhesives and bioelectronics.
Long-term outcomes and patterns of recurrence in mucinous rectal adenocarcinoma: A KCRG multicenter study.
123 Background: Mucinous adenocarcinoma is a poor prognostic indicator of colorectal cancer. Due to its rarity, mucinous colon and rectal cancers are frequently analyzed together, and studies specifically addressing mucinous rectal adenocarcinoma are limited. Consequently, data on the clinical characteristics and prognostic factors contributing to poor outcomes remain scarce. Methods: Utilizing a multi-institutional database from KCRG 19 institutions, we conducted a retrospective analysis of patients with clinical stage II/III rectal cancer who underwent primary surgery between January 2018 and December 2022. Patients were categorized into mucinous rectal adenocarcinoma (MRA) and non-mucinous rectal adenocarcinoma (NMRA) groups for analysis. Patient characteristics, long-term outcomes, and recurrence patterns were compared between the groups. Results: Among the 1,311 patients, 42 (3.2%) were diagnosed with MRA and 1,269 (96.8%) with NMRA. In the MRA group, 21 patients (50%) presented with clinical T4 disease, compared with 353 patients (27.8%) in the NMRA group. Combined resection of adjacent organs was more frequently required in the MRA group (RD 11.3%, 95%CI −1.3 to 23.8), whereas the R0 resection rate was lower (RD −13.3%, 95%CI −24.6 to −2.0). The 5-year overall survival was significantly lower in the MRA group (71.5% vs. 84.6%; HR 2.63, 95% CI 1.35–5.26), and the 5-year recurrence-free survival was also lower (57.5% vs. 70.7%; HR 1.85, 95% CI 1.11–3.13). The 5-year cumulative incidence of peritoneal recurrence was significantly higher in the MRA group (12.1% vs. 2.9%, Gray’s test P=0.001), whereas no significant differences were observed in local recurrence (5.7% vs. 4.1%, P=0.480), liver metastasis, or lung metastasis. The median survival time after recurrence was 25.4 months in the MRA group compared with 52.9 months in the NMRA group. Conclusions: In this cohort, the incidence of local recurrence in MRA was not markedly high, suggesting that local disease control may have been achieved through advances in neoadjuvant therapy and surgical techniques. However, the high incidence of peritoneal recurrence and poor survival indicate that improving outcomes in MRA requires treatment strategies that address systemic recurrence, in addition to local control.
Doxycycline modulation of the CD39/CD73–adenosine axis to enhance CD8⁺ T cell and M1 macrophage immunity in patient-derived breast cancer samples.
33 Background: The CD39/CD73–adenosine axis functions as a metabolic immune checkpoint in breast cancer by converting extracellular ATP into immunosuppressive adenosine. This pathway promotes M2-like macrophage polarization, suppresses cytotoxic CD8⁺ T-cell activity, enhances regulatory T-cell (Treg) expansion, and facilitates tumor progression. Doxycycline, a widely used antibiotic, has emerging immunomodulatory properties; however, its role in modulating adenosine-mediated immune suppression in human breast cancer remains undefined. This study evaluated the immunometabolism effects of doxycycline across triple-negative (TNBC), HER2⁺, and ER/PR⁺ breast cancer patients. Methods: Peripheral blood mononuclear cells (PBMCs) and matched tumor biopsies were collected from patients across breast cancer subtypes. PBMCs were stimulated with tumor-conditioned media and treated with doxycycline or adenosine-pathway inhibitors (ARL67156, AMPCP). Flow cytometry assessed CD39⁺/CD73⁺ Tregs, CD8⁺ T-cell activation, IFN-γ production, and macrophage phenotypes (M1/M2). Tumor biopsies underwent gene expression and immunohistochemical analysis for CD39, CD73, ENTPD1, and NT5E. Neutrophil-to-lymphocyte ratio (NLR) was correlated with CD39/CD73 expression. Results: Doxycycline significantly reduced CD39 and CD73 expression in tumor-conditioned and patient-derived PBMCs. Treatment decreased CD4⁺FoxP3⁺CD39⁺ Tregs while enhancing CD8⁺ T-cell activation and IFN-γ secretion. Doxycycline promoted M1 macrophage polarization and reduced M2-like phenotypes. These immunomodulatory effects were most pronounced in TNBC samples, consistent with elevated baseline CD39/CD73 expression in TNBC tissues. Combination treatment with ARL67156 further enhanced CD8⁺ cytotoxic responses and M1 polarization. Tumor biopsy analyses confirmed suppression of CD39/CD73 and ENTPD1/NT5E expression following doxycycline exposure. Elevated NLR positively correlated with CD39/CD73 levels, particularly in TNBC patients. Conclusions: Doxycycline acts as a low-cost metabolic immune-checkpoint modulator capable of reversing adenosine-driven immunosuppression in breast cancer, especially TNBC. These findings support further clinical investigation of doxycycline as a complementary immunotherapeutic strategy.
Modular Framework for 3D Molecular Generation in Computational Chemistry Applications
Poisoning‐Resistant Complete Hydrogenation of Liquid Organic Hydrogen Carriers Over Ni‐Based Inverse Catalysts
ABSTRACT Efficient hydrogen storage using liquid organic hydrogen carriers (LOHCs) requires catalysts that combine high low‐temperature activity with robustness against impure H 2 feeds. Conventional supported Ni catalysts are hindered by strong substrate adsorption and consequent site poisoning. Herein, a Ni based inverse catalyst consisting of CeZrO x clusters supported on metallic Ni is designed, which achieves >99.9% yield in the complete hydrogenation of diverse LOHCs—including mono‐, bi‐, and triphenyl‐type N‐heterocyclic and purely aromatic substrates—at low‐temperature of 130°C, exhibiting a 200‐fold higher activity than conventional Ni catalysts. Key to this performance is the oxide‐induced polarization of Ni atoms (Ni δ+ ), creating a thermodynamic stable subsurface reservoir and migration routes for dissociated H* species. Through this hydrogen transport pathway, hydrogen can efficiently hydrogenate the strongly adsorbed LOHCs. The significantly lowered H 2 kinetic order confirms the increased surface H* coverage in this inverse configuration. Decoupling the strong substrate adsorption sites and hydrogenation sites, the inverse configuration prevents self‐poisoning, enabling complete hydrogenation using crude H 2 and solvent‐free LOHCs. This work highlights the superior substrate generality and complete‐hydrogenation capability of the Ni inverse catalyst, establishing such inverse systems as a versatile platform for mild and robust LOHC‐based hydrogen storage.
Gradient-guided layerwise adaptive noise injection for pre-trained language model fine-tuning
Nocturnal Intraocular Pressure Monitoring With a Soft Contact Lens Sensor for Glaucoma Management
ABSTRACT Measurement of nocturnal intraocular pressure (IOP) is essential for glaucoma management, yet recumbent IOP fluctuations during sleep remain largely unmeasured outside the clinic. Although existing eye‐worn wearable sensors enable noninvasive IOP monitoring, limitations in sensitivity, closed‐eye performance, and overnight wearability restrict accurate assessment of nocturnal IOP changes under sleep conditions. Here, we present a soft contact lens sensor designed for continuous monitoring of nocturnal IOP in a home setting. The sensor integrates a compliant conductor–based inductive–capacitive circuit directly onto a commercial soft contact lens, enabling close conformity to the eye. This design achieves the highest IOP sensitivity reported to date among wearable soft contact lens sensors, representing a substantial improvement over our earlier designs. As a result, the sensor provides stable and accurate IOP measurements under recumbent, closed‐eye sleep conditions. Animal studies in rabbits and dogs and pilot human measurements in healthy and glaucomatous eyes support preliminary ocular tolerability and feasible sensor performance, enabling posture‐dependent IOP tracking and detection of sleep‐relevant pressure elevations under the tested conditions. These results address key limitations of earlier contact lens sensors and support at‐home monitoring of nocturnal IOP dynamics.
σ–p Hyperconjugation–Enabled Covalent Organic Frameworks for Programmable Cascaded Optical Modulation
ABSTRACT σ–p hyperconjugation is identified as an effective molecular lever for regulating the excited‐state behavior and donor characteristics of covalent organic frameworks (COFs). Activation of σ–p hyperconjugation amplifies the fluorescence quantum yield of COFs by up to 167‐fold, accompanied by a pronounced redistribution of excited‐state charge density. This atomic‐level electronic regulation enables programmable control over both the direction and magnitude of interfacial charge transfer in COF‐OMe/Eu@UiO‐66‐(COOH) 2 heterojunctions, giving rise to cascaded excitation–emission coupling and excitation‐dependent multicolor outputs. Perturbation of the hyperconjugation‐enhanced interface by hormone binding modulates the interfacial charge‐transfer landscape, resulting in distinct optical fingerprints that reflect subtle molecular stimuli. When incorporated into electrospun polyacrylonitrile membranes, these programmable optical responses are preserved in a flexible, antibacterial, and machine‐learning‐readable format, enabling rapid visual readout, quantitative concentration discrimination, and efficient solid‐phase extraction. Conceptually inspired by the multilayered optical modulation of chameleon skin, this work establishes σ–p hyperconjugation as a general design principle for constructing electronically adaptive COF–MOF heterostructures capable of transducing molecular perturbations into tunable optical signals.
Characterizing plasma circulating tumor RNA (ctRNA) landscape in advanced NSCLC: Preliminary insights into treatment resistance and tumor microenvironment.
167 Background: Plasma circulating tumor RNA (ctRNA) is currently used for gene fusion detection in non–small cell lung cancer (NSCLC). Beyond the detection of gene fusions, plasma ctRNA profiling has the potential to capture tumor-intrinsic transcriptional programs and features of the tumor microenvironment (TME). This may complement genomic profiling via ctDNA which is limited by tumor shedding. This exploratory study evaluated the feasibility of plasma ctRNA expression to identify molecular features associated with treatment response and acquired resistance in NSCLC. Methods: Plasma samples (n=115; 100 treatment-naïve and 15 EGFR -mutant at progression [PD]) were analyzed via amplicon-based targeted NGS. Expression levels were normalized to the geometric mean of control genes and log-transformed. Two primary analyses were conducted: (1) baseline differential expression comparing responders (R) versus non-responders (NR), and (2) comparative analysis of baseline EGFR -mutant samples versus those at PD to identify resistance-associated transcriptional shifts and pathway enrichment. Additionally, a curated panel of immune signatures—encompassing T-cell cytotoxicity, recruitment, exhaustion, B-cell/APC niches, and myeloid suppression—was utilized to characterize the baseline immune landscape from plasma. Results: At baseline, higher expression of CD70 and CD8B correlated with NR status in patients receiving chemotherapy plus immune checkpoint inhibitors (ICI). However, no significant differential expression patterns were identified in other treatment cohorts relative to response. The custom immune signature panel revealed significant inter-patient heterogeneity, successfully capturing distinct immune phenotypes—ranging from "inflamed" to "immune-excluded" (cold) barriers—directly from plasma. In the EGFR-mutant cohort at the point of TKI progression, significant upregulation was observed in genes associated with: TGF-β signaling and extracellular matrix organization (p < 10 -5 ), DNA damage response pathways (p <10 -4 ), immune regulatory and suppressive signatures (p <0.05). Conclusions: Preliminary evidence suggests that plasma ctRNA captures critical shifts in the TME that are not visible via ctDNA alone. The ability to profile immune exhaustion and myeloid suppression signatures using a specialized transcriptomic panel offers a potential framework for non-invasive, personalized immunotherapy selection. These data support the clinical utility of ctRNA as a tool for identifying therapeutic vulnerabilities. Further validation in larger, longitudinal cohorts is required to confirm these signatures as predictive biomarkers.
Disease-specific safety risks in oncology large language models: A multi-axis evaluation across solid tumor subtypes.
19 Background: Large language models (LLMs) are increasingly explored for oncology clinical decision support; however, safety risks related to hallucinations and guideline misalignment remain poorly characterized in solid tumors, where management is highly dependent on biomarker status, disease state, and multimodality sequencing. Aggregate performance metrics may obscure disease-specific vulnerabilities that are critical for safe clinical deployment. Methods: We curated 186 solid-tumor tumor-board vignettes spanning five disease domains: breast cancer (n=50), gastrointestinal cancers (n=50), genitourinary cancers (n=30), CNS metastases (n=50), and gynecologic oncology (n=50). Each vignette was evaluated using three configurations: (1) an unconstrained LLM, (2) an NCCN-anchored retrieval-augmented generation (RAG) system, and (3) a literature-anchored RAG system. Two board-certified oncologists independently scored outputs using a modified Generative Performance Score (mGPS; −1 to +1), incorporating guideline concordance (0.00–1.00) and hallucination penalties (0.00 to −1.00). Overall safety disparity was conservatively assigned as the maximum severity across axes and classified as low, intermediate, high, or severe. Readability and rationality were scored separately (Likert 1–5). Results: Safety-aligned performance varied markedly by solid tumor subtype. Breast cancer outputs were predominantly low-to-intermediate risk (88%), with high-disparity cases driven primarily by biomarker-dependent guideline misalignment. GI cancers demonstrated increased vulnerability (32% high disparity), reflecting multidisciplinary complexity and biomarker omission. CNS metastases (80%) and gynecologic oncology (70%) exhibited the highest proportions of high-disparity outputs, frequently driven by combined hallucination and guideline failures in multimodality or rare-disease contexts. Across all subtypes, NCCN-anchored RAG improved mean mGPS and reduced hallucination penalties compared with unconstrained and literature-anchored systems but did not eliminate high-risk failures. Readability remained moderate to high across systems and showed poor correlation with safety, frequently masking clinically unsafe recommendations. Conclusions: In solid tumors, LLM safety is highly disease-dependent and strongly influenced by evidence-source constraints. Guideline-anchored retrieval improves safety but is insufficient in complex solid tumor settings. Fluent presentation frequently masks safety-critical failures. These findings support the need for disease-specific, multi-axis safety evaluation frameworks and deployment guardrails prior to clinical use of LLM-based oncology decision support.
Direct Photoredox Synthesis of <i>N</i> -Linked Glycoproteins
Asymmetric α‐Alkylation With Activated and Unactivated Electrophiles by a Highly Productive and Recyclable Lewis Acid/Imidazolium Catalyst
ABSTRACT Asymmetric alkylation is widely used for the construction of α‐stereogenic carbonyl compounds, yet existing catalytic protocols typically suffer from several issues: (1) a limitation to π‐activated electrophiles, (2) the need for unsatisfying catalyst loadings, (3) a lack of catalyst recyclability, and (4) sophisticated catalyst structures requiring multi‐step syntheses. Herein, an efficiently accessible, air‐stable bifunctional Cu(II)/imidazolium catalyst (prepared over four steps without chromatographies in 74% yield) is reported that enables highly enantioselective α‐alkylations of 1,3‐dicarbonyls with unmet productivity (TON up to 1740). The catalyst exhibits broad electrophile compatibility, efficiently engaging π‐activated and non‐π‐activated alkylation agents. Remarkably, stereoretentive allylation with ( E )‐ and ( Z )‐configured allylbromides was achieved. The catalyst can be recycled over multiple cycles (10+) without loss of efficiency by a simple protocol. EPR proves formation of a Cu(II)‐enolate as resting state, for which detailed DFT calculations show that it is structurally anchored by hydrogen‐bonding to the imidazolium C(2) H . This feature is essential for stereodifferentiation of both enolate faces. A continuous mechanistic shift from S N 1‐like to S N 2‐type pathways is likely, depending on the electronic properties of the electrophile. This new alkylation concept allows for high practicality, combined with broad applicability and might serve as design prototype for future alkylation catalysts.
Nanometer scale imaging to develop quantitative descriptors of bipolar membrane junction structure
Abstract Swings in pH can be achieved by electrically polarizing a bipolar membrane (BPM) to drive water dissociation at the BPM junction for electrochemical conversion and separation processes. BPM junction design is critical to tailor performance for specific applications; however, characterization techniques capable of resolving the nanometer scale physical structure of the junction are limited. We present sample preparation, imaging, and analysis workflows that are adaptable to a variety of BPM junction architectures. Atomic force microscopy produces BPM junction images with nanometer scale lateral resolution for samples with and without a graphene oxide water dissociation catalyst in the junction. Subsequent image segmentation and analysis quantify line edge roughness and catalyst layer thickness as descriptors of junction structure. Comparison of pre- and post-electrodialysis junctions suggests electric field-induced alignment of catalyst particles during electrodialysis. This characterization workflow can inform manufacturing protocols, computational modeling, and failure mode analysis for next-generation BPMs.
On‐Water Surface Synthesis of 2D Conjugated Metal–Organic Framework Films With Controllable Layer Orientation Enabling High‐Performance Chemiresistive Sensing
ABSTRACT Two‐dimensional conjugated metal–organic frameworks (2D c ‐MOFs) offer an appealing platform for electronic devices, particularly chemiresistive sensors, owing to their unique combination of electrical conductivity and intrinsic porosity. However, their pronounced structural and transport anisotropies render device performance highly sensitive to layer orientation, underscoring the need for synthetic strategies that enable the controlled synthesis of well‐aligned 2D c ‐MOF films. Here, we introduce a surfactant monolayer‐assisted on‑water synthesis that programs the layer orientation of conductive Ni‑HHTP (HHTP = 2,3,6,7,10,11‐hexahydroxytriphenylene) films (face‑on vs. edge‑on) over cm 2 ‑scale areas by tuning ligand‐surfactant monolayer electrostatic vs. hydrogen‑bonding interactions. Imaging and scattering techniques unambiguously confirm preferential face‐on and edge‐on layer orientations, while electrical transport and optical pump‐THz probe spectroscopy reveal markedly enhanced intralayer charge transport in face‐on films, motivating their integration into chemiresistive sensing. Chemiresistive NH 3 sensors based on face‑on Ni‑HHTP films achieve a response of 269.8% at 50 ppm and an ultralow detection limit of 8.45 ppb at room temperature, surpassing edge‑on films and previously reported 2D c ‑MOF sensors. These results establish surfactant‐programmed on‐water synthesis as a new route to macroscopic orientation control in 2D c ‐MOFs, enabling deliberate exploitation of their anisotropic charge transport in high‐performance sensing and electronic devices.